Dr. Walter Kraft, MD

• Vascular Medicine

• Pharmacology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Thomas Jefferson University Hospitals

  Fellowship Hospital

• Thomas Jefferson University Hospitals

  Residency Hospital

• Thomas Jefferson University Hospitals

  Internship Hospital

• University Of Pittsburgh School Of Medicine

  Medical School, 1995

• Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling, 2018-01-16

• Diurnal variation of the human adipose transcriptome and the link to metabolic disease, 2009-02-09

• Tumor necrosis factor inhibitors in psoriatic arthritis, 2017-05-22

• Acid peptic diseases: pharmacological approach to treatment, 2011-07-15

• A glycosylated recombinant human granulocyte colony stimulating factor produced in a novel protein production system (AVI-014) in healthy subjects: a first-in human, single dose, controlled study, 2009-01-28

• Twice-Daily Doravirine Overcomes the Interaction Effect from Once-Weekly Rifapentine and Isoniazid in Healthy Volunteers Lamet al., 2020-05-29

• Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome, 2012-08-30

• The Pharmacokinetics and Pharmacodynamics of Buprenorphine in Neonatal Abstinence Syndrome, 2018-04-28

• Simultaneous Quantitative LC-MS Method of Ketamine, Midazolam and their Metabolites (Dehydronorketamine, Norketamine and 1Hydroxymidazolam) for its Application in Patients on Extracorporeal Membrane Oxygenation (ECMO) Therapy, 2019-10-24

• Pharmacokinetics of Vaginal Progesterone in Pregnancy, 2019-06-15

• Ondansetron to Reduce Neonatal Opioid Withdrawal Severity A Randomized Clinical Trial, 2022-08-27

• SUBDERMAL ULTRASOUND CONTRAST AGENT INJECTION FOR SENTINEL LYMPH NODE IDENTIFICATION: AN ANALYSIS OF SAFETY AND CONTRAST DOSE IN HEALTHY VOLUNTEERS, 2017-12-05

• Bioactivity of oral linaclotide in human colorectum for cancer chemoprevention, 2017-04-10

• Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome, 2015-07-14

• Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients, 2019-04-23

• Buprenorphine in Neonatal Abstinence Syndrome, 2017-11-28

• Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects, 2019-12-12

• Drug interactions between direct-acting oral anticoagulants and calcineurin inhibitors during solid organ transplantation: considerations for therapy, 2019-07-04